Chengchi CHAO

Follow

Person

Shenzhen, Guangdong, CN

People

Patents Grantslast 30 patents

Information Patent Grant
MART-1(27-35) epitope-specific T cell receptor
- Patent number 12,134,637
- Issue date Nov 5, 2024
- BGI SHENZHEN
- Fei Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Col14A1-derived tumor antigen polypeptide and use thereof
- Patent number 11,612,643
- Issue date Mar 28, 2023
- GENOIMMUNE THERAPEUTICS CO, , LTD.
- Bo Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CACNA1H-derived tumor antigen polypeptide and use thereof
- Patent number 11,548,925
- Issue date Jan 10, 2023
- Genoimmune Therapeutics Co., Ltd.
- Guanglei Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MART-1(27-35) EPITOPE-SPECIFIC T CELL RECEPTOR
- Publication number 20220340638
- Publication date Oct 27, 2022
- BGI Shenzhen
- Fei WANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CACNA1H-DERIVED TUMOR ANTIGEN POLYPEPTIDE AND USE THEREOF
- Publication number 20200024316
- Publication date Jan 23, 2020
- Genoimmune Therapeutics Co., Ltd.
- Guanglei LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COL14A1-DERIVED TUMOR ANTIGEN POLYPEPTIDE AND USE THEREOF
- Publication number 20190224291
- Publication date Jul 25, 2019
- Genoimmune Therapeutics Co., Ltd.
- Bo LI
- C07 - ORGANIC CHEMISTRY